Alsuwaida Abdulkareem O, Bakhit Amaar A, Alsuwaida Feras A, Wadera Junaid J, Kfoury Hala M, Husain Sufia
Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia. E-mail.
Saudi Med J. 2018 Oct;39(10):990-993. doi: 10.15537/smj.2018.10.22435.
To examined the short and long-term outcome of class II lupus nephritis (LN). Methods: This retrospective study included patients with class II LN at their first renal biopsy between January 1996 and December 2016 in King Khaled University Hospital, Riyadh, Saudi Arabia. The rate of complete remission, worsening renal function, and histological transformation in the second biopsy were examined. Results: The study included 32 female patients with class II LN. The most frequent presentation (62.5% of patients) was hematuria with subnephrotic range proteinuria. The clinical presentation included acute kidney injury in 22% of patients, and 9.4% had nephrotic range proteinuria. Management with steroid monotherapy in 25 patients resulted in complete remission for 92% of these patients at 6 months. After a median follow up of 8 years, 2 patients had a doubling of their serum creatinine. During the follow up 17 patients (53%) needed a second biopsy, which revealed transformation to other classes (65%). Conclusions: Daily steroid monotherapy may be an appropriate first-line treatment for class II LN that presents with subnephrotic range proteinuria and normal kidney function. Patients with acute kidney injury and/or nephrotic range proteinuria may warrant more aggressive immunosuppressive regimens.
为了研究II型狼疮性肾炎(LN)的短期和长期预后。方法:这项回顾性研究纳入了1996年1月至2016年12月期间在沙特阿拉伯利雅得哈立德国王大学医院首次进行肾活检的II型LN患者。检查了第二次活检时的完全缓解率、肾功能恶化情况和组织学转变。结果:该研究纳入了32例II型LN女性患者。最常见的表现(62.5%的患者)是血尿伴亚肾病范围蛋白尿。临床表现包括22%的患者出现急性肾损伤,9.4%的患者有肾病范围蛋白尿。25例患者采用类固醇单一疗法治疗,其中92%的患者在6个月时完全缓解。中位随访8年后,2例患者的血清肌酐翻倍。在随访期间,17例患者(53%)需要进行第二次活检,结果显示转变为其他类型(65%)。结论:对于表现为亚肾病范围蛋白尿且肾功能正常的II型LN,每日类固醇单一疗法可能是合适的一线治疗方法。急性肾损伤和/或肾病范围蛋白尿的患者可能需要更积极的免疫抑制方案。